1415 related articles for article (PubMed ID: 29017448)
1. What is polypharmacy? A systematic review of definitions.
Masnoon N; Shakib S; Kalisch-Ellett L; Caughey GE
BMC Geriatr; 2017 Oct; 17(1):230. PubMed ID: 29017448
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences.
Pazan F; Wehling M
Eur Geriatr Med; 2021 Jun; 12(3):443-452. PubMed ID: 33694123
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy definition and prevalence in heart failure: a systematic review.
Beezer J; Al Hatrushi M; Husband A; Kurdi A; Forsyth P
Heart Fail Rev; 2022 Mar; 27(2):465-492. PubMed ID: 34213753
[TBL] [Abstract][Full Text] [Related]
6. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
7. The role of diseases, risk factors and symptoms in the definition of multimorbidity - a systematic review.
Willadsen TG; Bebe A; Køster-Rasmussen R; Jarbøl DE; Guassora AD; Waldorff FB; Reventlow S; Olivarius Nde F
Scand J Prim Health Care; 2016 Jun; 34(2):112-21. PubMed ID: 26954365
[TBL] [Abstract][Full Text] [Related]
8. Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review.
Tsang JY; Sperrin M; Blakeman T; Payne RA; Ashcroft D
BMJ Open; 2024 May; 14(5):e081698. PubMed ID: 38803265
[TBL] [Abstract][Full Text] [Related]
9. Defining pediatric polypharmacy: A scoping review.
Bakaki PM; Horace A; Dawson N; Winterstein A; Waldron J; Staley J; Pestana Knight EM; Meropol SB; Liu R; Johnson H; Golchin N; Feinstein JA; Bolen SD; Kleinman LC
PLoS One; 2018; 13(11):e0208047. PubMed ID: 30496322
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis.
Delara M; Murray L; Jafari B; Bahji A; Goodarzi Z; Kirkham J; Chowdhury M; Seitz DP
BMC Geriatr; 2022 Jul; 22(1):601. PubMed ID: 35854209
[TBL] [Abstract][Full Text] [Related]
11. Interventions to improve the appropriate use of polypharmacy for older people.
Rankin A; Cadogan CA; Patterson SM; Kerse N; Cardwell CR; Bradley MC; Ryan C; Hughes C
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD008165. PubMed ID: 30175841
[TBL] [Abstract][Full Text] [Related]
12. Defining polypharmacy in the elderly: a systematic review protocol.
Mortazavi SS; Shati M; Keshtkar A; Malakouti SK; Bazargan M; Assari S
BMJ Open; 2016 Mar; 6(3):e010989. PubMed ID: 27013600
[TBL] [Abstract][Full Text] [Related]
13. Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts-Results of a Literature Review.
Taghy N; Cambon L; Cohen JM; Dussart C
Ther Clin Risk Manag; 2020; 16():57-73. PubMed ID: 32103967
[TBL] [Abstract][Full Text] [Related]
14. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review.
Cooper JA; Cadogan CA; Patterson SM; Kerse N; Bradley MC; Ryan C; Hughes CM
BMJ Open; 2015 Dec; 5(12):e009235. PubMed ID: 26656020
[TBL] [Abstract][Full Text] [Related]
15. Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy.
Kadam UT; Roberts I; White S; Bednall R; Khunti K; Nilsson PM; Lawson CA
J Clin Epidemiol; 2019 Feb; 106():98-107. PubMed ID: 30385327
[TBL] [Abstract][Full Text] [Related]
16. A systematic scoping review of interventions to optimise medication prescribing and adherence in older adults with cancer.
Murphy M; Bennett K; Ryan S; Hughes CM; Lavan AH; Cadogan CA
Res Social Adm Pharm; 2022 Mar; 18(3):2392-2402. PubMed ID: 33903064
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
Hasan Ibrahim AS; Barry HE; Hughes CM
Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
[TBL] [Abstract][Full Text] [Related]
18. The measurement and monitoring of surgical adverse events.
Bruce J; Russell EM; Mollison J; Krukowski ZH
Health Technol Assess; 2001; 5(22):1-194. PubMed ID: 11532239
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy and pattern of medication use in community-dwelling older adults: A systematic review.
Hsu HF; Chen KM; Belcastro F; Chen YF
J Clin Nurs; 2021 Apr; 30(7-8):918-928. PubMed ID: 33325067
[TBL] [Abstract][Full Text] [Related]
20. A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol.
Martinez YV; Renom-Guiteras A; Reeves D; Erandie Ediriweera de Silva R; Esmail A; Kunnamo I; Rieckert A; Sommerauer C; Sönnichsen A
BMC Geriatr; 2017 Oct; 17(Suppl 1):231. PubMed ID: 29047332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
